The Conference
200+ Speakers. 4 Tracks. One Unmissable Event.
Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.
By bringing eight tracks together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine
& immunotherapy
research, development and manufacture.
Take just three days out of the office to meet over 500+ potential customers who need to find solutions to their challenges. Build three days of totally tailored content and attendees.
CONFERENCE STREAMS
Immune profiling in infectious disease and cancer
Develop an understanding of the rules of response and protection for vaccines and immunotherapies from novel biomarkers and assays to innovative new technologies disrupting the industry.
In oncology, learn about:
- The development of multi-dimensional biomarkers
- Next generation single cell sequencing
- Characterization of the tumor microenvironment
- The use of liquid biopsies as a diagnostic tool
In infectious disease, understand:
- How projects like the Immune Epitope Database accelerating the discovery of new targets
- The analysis of T-cell responses through TCR repertoire analysis
- Protection and waning immunity to current vaccines
- How far we’ve come towards an AI model of the human immune system
Cancer Immunotherapy
Stay up-to-date with the fast-moving world of cancer immunotherapy.
Learn more about:
- Neoantigen prediction and discovery
- Cancer vaccines and oncolytic viruses
- Engineered cell therapies and antibody-based therapies
- Checkpoint inhibitors and other immunomodulatory targets as monotherapies and in combination
Delve deeper into what the development of these therapies teaching us about understanding mechanisms of immune suppression and resistance, and how this informs new therapies that will overcome them.
Moving forward, what will be the impact of moving to earlier lines of therapy in cancer? Hear from key opinion leaders in oncology about how this affects the way with think about cancer immunotherapy strategies.
Vaccine Development
- Agenda topics include:
- National strategies to combat ant-microbial resistance
- Efforts to develop novel influenza vaccines from seasonal and pandemic
- Progress in the development of a universal flu vaccine
- Respiratory vaccines such as RSV and MERS
- Biotechs platforms to counter emerging threats such as Dengue, Malaria, Zika and Ebola
- Passive immunity strategies
- Development of antibody-based therapies against infectious diseases
Delivery Bioprocessing and Manufacture
Discover the latest technologies improving vaccine and and immunotherapy delivery including:
- Needle-free delivery systems
- Nano-patches
- Vector mediated antigen delivery
- The latest advances in the engineering of antibody therapies for selective binding, more stable linker technology
- Plant-based production platforms
- Scaling up of t-cell therapies
- Production platforms to respond to emerging threats
New Technology
New technologies are transforming both the vaccines and immunotherapy space.
Join us to learn about:
- The latest advances in bioinformatic tools
- Applications of machine learning and AI
- New platform technologies that are helping to accelerate therapies from bench to bedside
Pre-Clinical and Clinical Development
- The use of animal models to inform pre-clinical development
- Patient selection strategies
- Running clinical trials in an international setting
- Clinical efficacy, human challenge studies, real word evidence
- Phase 4 / 5 trials to support post-licensure safety studies
Sign Up for Event Updates
Contact us
To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156
oliver.breed@terrapinn.com
To speak:
Lauren Sheppard
+44 (0)207 092 1211
lauren.sheppard@terrapinn.com
Organiser
